NDC codes

416497 NDC codes with hospital pricing data in the network.

• NDC 00904-7276-41 — Nystatin oral suspension 100,000 units per mLAI (340 hospitals, 24,904–25,498 samples)
• NDC 65862-0177-60 — Cefdinir 300 mg capsulesAI (570 hospitals, 24,560–25,496 samples)
• NDC 58602-0604-07 — Diclofenac sodium 1% topical gelAI (322 hospitals, 24,650–25,496 samples)
• NDC 00168-0099-30 — ketoconazole 2 % topical creamAI (281 hospitals, 24,650–25,496 samples)
• NDC 63323-0820-50 — Intravenous fat emulsion, soybean and fish oil blendAI (305 hospitals, 25,253–25,496 samples)
• NDC 82260-0001-01 — Atropine sulfate eye drops, single-use dropperAI (45 hospitals, 24,650–25,496 samples)
• NDC 62135-0730-45 — Fluoxetine 20 mg/5 mL oral liquidAI (45 hospitals, 24,650–25,496 samples)
• NDC 68462-0609-35 — PIMECROLIMUS 1 % TOPICAL CREAMAI (121 hospitals, 24,631–25,495 samples)
• NDC 51672-4215-03 — METRONIDAZOLE 1 % TOPICAL GELAI (174 hospitals, 24,631–25,495 samples)
• NDC 43598-0129-25 — Methylprednisolone sodium succinate 125 mg injectionAI (376 hospitals, 15,777–25,488 samples)
• NDC 45802-0472-64 — Hydrocortisone and pramoxine cream, 30 g tubeAI (287 hospitals, 24,630–25,485 samples)
• NDC 65219-0570-04 — Bumetanide 0.25 mg/mL injection solutionAI (390 hospitals, 24,792–25,485 samples)
• NDC 72578-0093-01 — BETAMETHASONE DIPROPIONATE 0.05 % TOPICAL OINTMENTAI (131 hospitals, 24,630–25,485 samples)
• NDC 67877-0124-85 — SILVER SULFADIAZINE 1 % TOPICAL CREAMAI (113 hospitals, 24,630–25,485 samples)
• NDC 00071-1015-41 — pregabalin 100 mg capsuleAI (390 hospitals, 24,855–25,485 samples)
• NDC 00078-0799-75 — Ciprofloxacin and dexamethasone ear dropsAI (155 hospitals, 24,630–25,485 samples)
• NDC 45802-0129-32 — HALOBETASOL PROPIONATE 0.05 % TOPICAL CREAMAI (64 hospitals, 24,630–25,485 samples)
• NDC 49502-0900-01 — Selegiline 6 mg/24 hour transdermal patchAI (106 hospitals, 24,630–25,485 samples)
• NDC 33342-0321-86 — CLOBETASOL 0.05 % SCALP SOLUTIONAI (118 hospitals, 24,630–25,485 samples)
• NDC 00591-2944-30 — PIMECROLIMUS 1 % TOPICAL CREAMAI (94 hospitals, 24,630–25,485 samples)
• NDC 66993-0897-15 — Betamethasone 0.05% topical ointmentAI (103 hospitals, 24,630–25,485 samples)
• NDC 00781-7119-54 — Estradiol weekly transdermal patch, 0.025 mgAI (80 hospitals, 24,630–25,485 samples)
• NDC 69238-1745-08 — PILOCARPINE 1 % EYE DROPSAI (227 hospitals, 24,629–25,475 samples)
• NDC 68682-0464-10 — Brinzolamide 1% eye drop suspensionAI (304 hospitals, 24,629–25,475 samples)
• NDC 51079-0083-20 — Isoniazid 300 mg oral tabletsAI (453 hospitals, 24,977–25,472 samples)
• NDC 44567-0600-04 — dexmedeTOMIDine 100 mcg/mL intravenous solutionAI (195 hospitals, 25,166–25,472 samples)
• NDC 68084-0313-01 — Divalproex sodium 125 mg delayed-release capsuleAI (712 hospitals, 24,755–25,466 samples)
• NDC 68682-0455-70 — Metronidazole 0.75% vaginal gelAI (170 hospitals, 24,628–25,465 samples)
• NDC 00023-3615-25 — GATIFLOXACIN 0.5 % EYE DROPSAI (120 hospitals, 24,628–25,465 samples)
• NDC 16714-0526-01 — Ipratropium bromide nasal sprayAI (212 hospitals, 24,627–25,455 samples)
• NDC 00591-2127-79 — Brinzolamide 1% eye dropsAI (110 hospitals, 24,627–25,455 samples)
• NDC 16714-0628-01 — Ciprofloxacin and dexamethasone ear dropsAI (298 hospitals, 24,627–25,455 samples)
• NDC 65862-0306-12 — Fluoxetine oral liquid, 20 mg per 5 mLAI (217 hospitals, 24,626–25,445 samples)
• NDC 00378-9070-93 — Rivastigmine 4.6 mg/24-hour transdermal patchAI (310 hospitals, 24,626–25,445 samples)
• NDC 42023-0104-05 — Tuberculin skin test (PPD) injectionAI (234 hospitals, 24,910–25,441 samples)
• NDC 00904-6293-04 — atorvastatin 80 mg tabletAI (422 hospitals, 24,962–25,439 samples)
• NDC 00904-7227-61 — Clonazepam 0.5 mg tabletsAI (489 hospitals, 24,852–25,437 samples)
• NDC 63629-8713-01 — Estradiol vaginal creamAI (42 hospitals, 24,625–25,435 samples)
• NDC 66993-0936-61 — METRONIDAZOLE 1 % TOPICAL GELAI (97 hospitals, 24,625–25,435 samples)
• NDC 68682-0299-05 — Loteprednol etabonate 0.5% eye drop suspensionAI (173 hospitals, 24,625–25,435 samples)
• NDC 00037-6824-10 — Hydrocortisone and pramoxine topical foamAI (235 hospitals, 24,625–25,435 samples)
• NDC 16714-0763-01 — CALCIPOTRIENE 0.005 % TOPICAL CREAMAI (104 hospitals, 24,625–25,435 samples)
• NDC 00378-8770-35 — Estradiol vaginal creamAI (143 hospitals, 24,625–25,435 samples)
• NDC 00472-0379-45 — Clotrimazole and betamethasone topical creamAI (150 hospitals, 24,625–25,435 samples)
• NDC 00832-0465-30 — Nystatin 100,000 unit per gram topical powderAI (184 hospitals, 24,625–25,435 samples)
• NDC 16571-0723-48 — Mafenide acetate cream topicalAI (161 hospitals, 24,625–25,435 samples)
• NDC 16714-0055-01 — Mupirocin 2% topical creamAI (144 hospitals, 24,625–25,435 samples)
• NDC 16714-0178-01 — FLUOROURACIL 5 % TOPICAL CREAMAI (75 hospitals, 24,625–25,435 samples)
• NDC 16714-0878-02 — LIDOCAINE 5 % TOPICAL OINTMENTAI (65 hospitals, 24,625–25,435 samples)
• NDC 42291-0094-30 — Azelastine nasal sprayAI (211 hospitals, 24,625–25,435 samples)